Nuclear cGAS suppresses DNA repair and promotes tumorigenesis

Haipeng Liu1,2, Haiping Zhang3, Xiangyang Wu1,2

  • 1Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.

Nature
|October 26, 2018
PubMed

Insights

Cyclic GMP-AMP synthase (cGAS) suppresses DNA repair by inhibiting homologous recombination. Inhibiting cGAS reduces DNA damage and tumor growth, suggesting it as a cancer therapy target.

Area of Science:

  • Molecular Biology
  • Immunology
  • Cancer Research

Background:

  • Homologous recombination repairs DNA double-stranded breaks, maintaining genome stability and preventing cancer.
  • Cyclic GMP-AMP synthase (cGAS) is a cytosolic DNA sensor crucial for innate immunity.
  • The role of cGAS in DNA repair pathways was previously unknown.

Purpose of the Study:

  • To investigate the role of cGAS in DNA repair, specifically homologous recombination.
  • To elucidate the mechanism by which cGAS influences DNA repair.
  • To evaluate the therapeutic potential of targeting cGAS in cancer.

Main Methods:

  • Investigated cGAS localization and function in response to DNA damage in mouse and human cells.
  • Utilized importin-α and B-lymphoid tyrosine kinase (BLK) to study cGAS nuclear translocation and phosphorylation.
  • Examined the interaction between cGAS, PARP1, and the PARP1-Timeless complex at DNA double-stranded breaks.
  • Assessed the impact of cGAS knockdown on DNA damage and tumor growth in vitro and in vivo.

Main Results:

  • DNA damage triggers nuclear translocation of cGAS, facilitated by importin-α and BLK-mediated phosphorylation.
  • Nuclear cGAS interacts with PARP1, disrupting the PARP1-Timeless complex and suppressing homologous recombination.
  • Knockdown of cGAS significantly reduces DNA damage and inhibits tumor growth.

Conclusions:

  • Nuclear cGAS acts as a suppressor of homologous recombination-mediated DNA repair.
  • cGAS promotes tumor growth by inhibiting essential DNA repair mechanisms.
  • Targeting cGAS presents a promising strategy for cancer prevention and therapy.